CD38 Pretargeted Radioimmunotherapy for Myeloma

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert Zygmunt Orlowski

Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Multiple myeloma and immunoproliferative diseases

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Prostate Pancreas Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Melanoma of skin Leukaemia Colorectum Breast Bladder

Catriona HM Jamieson

(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Lindsay Morton

Childhood cancer survivor study (CCSS)

Sarcoma Thyroid Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Lip, oral cavity Leukaemia Larynx Kidney, renal pelvis and ureter Hodgkin lymphoma Breast Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer